Document:

EX-10.2

 

Exhibit 10.2

	 
	EMPLOYMENT AGREEMENT

 

This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of the date of the closing of
acquisition by The Lubrizol Corporation, an Ohio Corporation of Noveon International, Inc.
(“Effective Date”), by and between Noveon, Inc., a Delaware corporation (the “Company”), and
Julian Steinberg (the “Employee”);

	 
	WITNESSETH

 

WHEREAS, the Employee is a senior executive of the Company and has made and is expected to
continue to make major contributions to the profitability, growth and financial strength of the
Company;

WHEREAS, the Company desires to encourage Employee to remain with the Company for a number of
years.

WHEREAS, this Agreement is not intended to alter materially the compensation and benefits
which the Employee could reasonably expect to receive from the Company that are not addressed
within this Agreement; and

WHEREAS, the Employee is willing to render services to the Company on the terms and subject
to the conditions set forth in this Agreement;

NOW, THEREFORE, the Company and the Employee agree as follows:

	1.	 	Subject to Section 7, if the Executive remains in the employ of the Company until the
4th anniversary of the Effective Date, he will receive the value, less applicable taxes,
of 10,000 retention units determined as of the 4th anniversary of the Effective Date.
	 
	2.	 	Subject to Section 7, if Employee terminates employment with the Company before the
4th anniversary of the Effective Date, Employee will receive the value less applicable
taxes, of the corresponding number of retention units determined as of the date of termination
pursuant to the following schedule:

	 	 	 	 	 	 	 	 
	 	Termination Date

	 	 	Number of Retention Units
	 
	 	Less than 1 year after Effective Date

	 	 	 	0	 	 
	 	1 year after Effective Date but less than 2 years after Effective Date

	 	 	 	3,000	 	 
	 	2 years after Effective Date but less than 3 years after Effective Date

	 	 	 	5,000	 	 
	 	3 years after Effective Date but less than 4 years after Effective Date

	 	 	 	7,000	 	 
	 

	3.	 	The value of one retention unit equals the value of one share of Lubrizol common stock based on
the closing price of a share of Lubrizol common stock on the applicable date as reported on the
NYSE composite tape.
	 
	4.	 	Any amount payable to Employee under this Agreement will be made within 30 days of the
applicable date.
	 
	5.	 	Employee further agrees as follows:

	 	(a)	 	Employee agrees and acknowledges that the term “Confidential and Proprietary
Information” means any and all information not in the public domain, in any form, emanating
from or relating to Company or its subsidiaries, branches

 

 

	 	 	 	and affiliates, including, but not limited to, trade secrets, technical information,
methods of operation and procedures, know-how, improvements, price lists, financial data,
invoices and financial statements, computer programs, discs and printouts, sketches, and
plans (engineering or otherwise), customer lists, telephone numbers, names, addresses, or
any other compilation of information written or unwritten which is used in the business of
Company or any of its subsidiaries, branches or affiliates. For the purpose of this
paragraph (a), the term “affiliate” means a person that directly or indirectly controls, or
is controlled by, or is under common control with, Company. Employee agrees and
acknowledges that all Confidential and Proprietary Information, in any form, and copies and
extracts thereof, is and are and will remain the sole and exclusive property of Company and
upon termination of Employee’s employment with Company, Employee agrees to return to
Company the originals and all copies of any Confidential and Proprietary Information
provided to or acquired by Employee during the period of his employment. Employee
expressly agrees not to use the Confidential and Proprietary Information himself or for
others in any manner which is detrimental to the interests of Company and never to disclose
to any person (except to other of Company’s directors, employees, and official
representatives, and then only on a “need-to-know” basis) or entity any Confidential and
Proprietary Information of Company either during the term of his employment or at any time
after termination of such employment, except upon the express written authorization and
consent of Company. Nothing contained herein shall be construed as restricting or creating
any liability for the disclosure, communication, or use of Confidential and Proprietary
Information that is disclosed as required by law or legal process. In the even that
Employee is requested or required by law or legal process to disclose any of the
Confidential and Proprietary Information, Employee shall provide the Company with prompt
oral and confirming written notice, unless notice is prohibited by law (in which case such
notice shall be provided as early as may be legally permissible), of any such request or
requirement so the Company may seek a protective order or other appropriate remedy.
Employee agrees to cooperate with Company, at the Company’s expense, in any efforts to
obtain such remedies, but this provision shall not be construed to require Employee to
undertake litigation or other legal proceedings on Employee’s own behalf. In the event
that such protective order or other remedy is not promptly obtained, Employee may disclose
such Confidential and Proprietary Information.
	 
	 	(b)	 	Employee understands and acknowledges that each customer of Company will disclose
information concerning the customer’s business, which information will be within Company’s
control in connection with Company’s furnishing of products and/or services to its
customer. Employee covenants and agrees to hold such information in the strictest
confidence and shall treat such information in the same manner and be obligated by the
provisions of this Agreement as if such information were Confidential and Proprietary
Information, as defined in Section 5(a) above.

	6.	 	Employee further agrees as follows:

	 	(a)	 	Employee hereby assigns to Company the entire right, title and interest of Employee in
all inventions, discoveries, improvements, developments and ideas, including, but not
limited to, utility, design or plant patents, invention certificates, statutory invention
registrations, copyrights, computer programs, trademarks, trade secrets, whether or not
patentable (collectively “Inventions”), hereafter

2

 

	 	 	 	made or conceived by him, solely or jointly with others, during his employment,
or which are conceived or reduced to practice within one year following the termination of
employment hereunder.
	 
	 	(b)	 	This Section 6 does not apply to any Invention for which no equipment, supplies,
facilities, or trade secrets of Company are used and which is developed entirely on
Employee’s own time, unless

	 	(i)	 	the Invention relates to the business of Company, or relates to Employer’s
actual or demonstrably anticipated research and development, or
	 
	 	(ii)	 	the Invention results from any work performed by Employee for Company.
Employee further understands that he has the burden of establishing any exception
described in this paragraph (b).

	 	(c)	 	Employee agrees that in connection with each Invention covered by paragraph (a) above:

	 	(i)	 	he will communicate the fact of the Invention promptly and fully to Company or
its designee and, if requested, make a specific assignment of title thereto to
Company or its designee;
	 
	 	(ii)	 	he will keep and maintain adequate and current written records thereof at all
stages, in the form of notes, sketches, drawings, and reports relating thereto,
which records shall be and remain the property of and be available to Company at
all times; and
	 
	 	(iii)	 	he will, during and after his employment by Company, without charge to
Company for his time but at its request and expense, assist Company and its
designees in every proper way to obtain and to cause to be vested in it or them
title to each Invention in all countries selected by Company, by executing all
necessary or desirable documents, including applications for patents and
assignments thereof, and otherwise assist Company at no expense to himself in the
prosecution for any Invention or in any litigation or other matter.

	 	(d)	 	Employee represents that there are no Inventions conceived by him prior to his
employment by Company which are excluded from the provisions of this Section 6, except the
following:

	 	(i)	 	Inventions, if any, already published or disclosed in patents, applications,
statutory invention registrations or invention certificates already filed in the
United States or a foreign country;
	 
	 	(ii)	 	Others: None

	 	(e)	 	Except with the prior written permission of Company, Employee will not disclose to
anyone other than the employees or official representatives, of Company, or use in other
than Company’s business, any of Company’s Inventions during or after his employment by
Company, unless and until and only to the extent that any such Inventions become public
knowledge and available for public use otherwise than by his act or omission.

3

 

	 	(f)	 	Employee will not disclose to Company or induce Company to use, any inventions or
confidential information or data belonging to others.

	7.	 	Company may terminate this Agreement at any time for cause. If Employee is terminated for
cause, Company will have no further obligation to Employee under this Agreement. For cause
termination means the following:

	 	(a)	 	Employee’s breach of the patent covenants set forth in Section 6 hereof;
	 
	 	(b)	 	Employee’s material breach of the confidentiality covenants set forth in Section 5
hereof;
	 
	 	(c)	 	dishonest or obvious and willful misconduct by Employee; or
	 
	 	(d)	 	the conviction of a felony.

     For the purposes of this Section 7, cause does not include Employee’s refusal to relocate to
another city.

	8.	 	If the Company terminates Employee’s employment for reasons other than those specified in
Section 7, Employee will receive the following (less any applicable taxes):

	 	(a)	 	lump sum cash payment equal to one year’s base salary, paid within 30 days of the date
of termination;
	 
	 	(b)	 	pro-rated bonus paid based on actual results for the year of termination; and
	 
	 	(c)	 	COBRA coverage paid by the Company under Company’s medical and dental program for the
period ending 12 months after the date of termination, or Employee’s ineligibility for
further coverage under the COBRA rules, whichever is earlier.

In addition, if Company terminates Employee’s employment for reasons other than those specified in
Section 7 prior to the 4th anniversary of this Agreement the Employee will receive, in
lieu of the retention units specified in accordance with the schedule in Section 2, the value of
10,000 retention units determined as of the date of termination, paid within 30 days of the date of
termination.

	9.	 	Termination of this Agreement does not terminate Employee’s obligations of the confidentiality
and patents covenants of Sections 5 and 6.
	 
	10.	 	If any section, sub-section, paragraph or portion of this Agreement is, for any reason,
adjudged by a court of competent jurisdiction to be invalid or unenforceable, such judgment will
not affect, impair, or invalidate the remainder of this Agreement, but will be confined in its
operation to the provisions of this Agreement directly involved in the controversy in which such
judgment is rendered.
	 
	11.	 	This Agreement will in all respects be governed, construed, and enforced in accordance with the
laws of the State of Ohio, excluding its principles of conflicts of law, and the parties hereto
irrevocably commit to the jurisdiction of the courts of the State of Ohio, to resolve any disputes
arising hereunder or related hereto.

4

 

	12.	 	This Agreement may be executed in one or more counterparts, each of which will be deemed to be
an original but all of which together will constitute one and the same agreement.

IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed and delivered
as of the date first above written.

	 	 	 	 	 	 	 	 	 
	EMPLOYEE	 	 	 	NOVEON, INC.	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	By:	 	 	 	 
	 

	 	 	 	 	 	 

President
	 	 

5EX-10.1

 

Exhibit 10.1

PLACEMENT AGENCY AGREEMENT

November 8, 2007

Stephens Inc.

111 Center Street

Little Rock, Arkansas 72201

Ladies and Gentlemen:

     Ultralife Batteries, Inc., a Delaware corporation (the “Company”), proposes to sell to certain
investors (collectively, the “Investors”) up to an aggregate of 1,000,000 shares (the “Shares”) of
Common Stock, $.10 par value per share (the “Common Stock”), of the Company. Pursuant to this
Agreement, the Company engages Stephens Inc. (the “Placement Agent”) as the exclusive placement
agent in connection with the sale of the Shares. The Shares are described in the Prospectus that is
referred to below.

     The Company has prepared and filed, in accordance with the Securities Act of 1933, as amended,
and the rules and regulations thereunder (collectively, the “Act”), with the Securities and
Exchange Commission (the “Commission”) a registration statement on Form S-3 (File No. 333-136742)
dated August 18, 2006 (the “registration statement”). The registration statement has been declared
by the Commission to be effective under the Act. The Company will next file with the Commission
pursuant to Rule 424(b) under the Act a final prospectus supplement to the Basic Prospectus (as
defined below), describing the Shares and the offering thereof, in substantially such form as has
been provided to and approved by the Placement Agent.

     The term “Registration Statement” as used in this Agreement means the registration statement,
at the time it became effective and as supplemented or amended prior to the execution of this
Agreement, including (i) all financial schedules and exhibits thereto and (ii) all documents
incorporated by reference or deemed to be incorporated by reference therein. The term “Basic
Prospectus” as used in this Agreement means the prospectus included in the registration statement
at the time it became effective. The term “Prospectus Supplement” as used in this Agreement means
the final prospectus supplement which the Company will file with the Commission pursuant to Rule
424(b) under the Act, on or before the first business day following execution of this Agreement.
The term “Prospectus” as used in this Agreement means the Basic Prospectus together with the
Prospectus Supplement except that if such Basic Prospectus is amended or supplemented on or prior
to the date of the Prospectus Supplement, the term “Prospectus” shall refer to the Basic Prospectus
as so amended or supplemented and as supplemented by the Prospectus Supplement. Any reference
herein to the Registration Statement, the Basic Prospectus, the Prospectus Supplement or the
Prospectus shall be deemed to refer to and include (i) the documents incorporated by reference
therein and (ii) the copy of the Registration Statement, the Basic Prospectus, the Prospectus
Supplement or the Prospectus filed with the Commission pursuant to its Electronic Data Gathering,
Analysis and Retrieval system (“EDGAR”). Any reference herein to the terms “amend,” “amendment” or
“supplement” with respect to the Registration Statement, the Basic Prospectus, the Prospectus
Supplement or the

 

 

Prospectus shall be deemed to refer to and include the filing of any document under the
Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder
(collectively, the “Exchange Act”) after the effective date of the Registration Statement, or the
date of the Prospectus, as the case may be, deemed to be incorporated therein by reference. As used
herein, “business day” shall mean a day on which the NASDAQ Global Market is open for trading.

     The term “Disclosure Package” shall mean (i) the Prospectus as of the date and time of
execution of this Agreement, (ii) the issuer free writing prospectuses as defined in Rule 433 under
the Act (each, an “Issuer Free Writing Prospectus”), if any, identified in Exhibit A hereto and
(iii) any other free writing prospectus that the parties hereto shall hereafter expressly agree in
writing to treat as part of the Disclosure Package.

     The Company hereby confirms its agreement with the Placement Agent as follows:

     1. Agreement to Act as Placement Agent.

     (a) On the basis of the representations and warranties of the Company set forth in
Section 4 hereof and subject to the terms and conditions set forth in this Agreement, the
Company hereby engages the Placement Agent to act as the exclusive placement agent, on a
reasonable efforts basis, in connection with the offer and sale by the Company of Shares to
the Investors. As compensation for services rendered, at the time of purchase (as defined in
Section 2 hereof) the Company shall pay to the Placement Agent, by Federal Funds wire
transfer to an account or accounts designated by the Placement Agent, an amount equal to
5.0% of the gross proceeds received by the Company from the sale of the Shares at the time
of purchase. Notwithstanding the immediately preceding sentence, the minimum amount payable
to the Placement Agent upon the closing of the offering of the Shares shall be $500,000;
provided, however, that in no event shall the total amount payable to the Placement Agent
(or any other member of the Financial Industry Regulatory Authority (“FINRA”) or any
independent broker or dealer in the offering) exceed 8.0% of the gross proceeds received by
the Company from the sale of the Shares. The Shares are being sold at a price of $13.50 per
share of Common Stock.

     (b) In soliciting purchases of Shares, the Placement Agent shall act solely as the
Company’s agent and not as principal, and this Agreement shall not give rise to any
commitment by the Placement Agent or any of its affiliates to underwrite or purchase any of
the Shares. Notwithstanding the foregoing, it is understood and agreed that the Placement
Agent or its affiliates may, solely at their discretion and without any obligation to do so,
purchase Shares as principals; provided, however, that any such purchases by the Placement
Agent or its affiliates shall be fully disclosed to the Company, including the identity of
such Investors, and accepted by the Company in accordance with Section 1(c).

     (c) Offers for the purchase of Shares may be solicited by the Placement Agent at such
times and in such amounts as the Placement Agent deems advisable. The

2

 

Placement Agent may also retain other brokers or dealers to act as sub-agents on its
behalf in connection with the offering and sale of the Shares. Until the earlier of the time
of purchase or the termination of this Agreement, the Company shall not, without the prior
written consent of the Placement Agent, solicit or accept offers to purchase Shares other
than through the Placement Agent. The Placement Agent shall have no authority to bind the
Company in respect of the sale of any Shares. The Placement Agent shall communicate, orally
or in writing, to the Company each reasonable offer or indication of interest received by it
to purchase Shares. The Company shall have the sole right to accept offers to purchase the
Shares and may reject any such offer in whole or in part. The Placement Agent shall make
commercially reasonable efforts to assist the Company in obtaining performance by each
Investor whose offer to purchase Shares has been solicited by the Placement Agent and
accepted by the Company, but the Placement Agent shall not have any liability to the Company
in the event any such purchase is not consummated for any reason. If the Company shall
default in its obligation to deliver Shares to an Investor whose offer it has accepted, the
Company shall indemnify and hold harmless the Placement Agent against any loss, claim,
damage or expense arising from or as a result of such default by the Company.

     2. Payment and Delivery. Subject to the terms and conditions hereof, payment of the purchase
price for the Shares shall be made at the office of Stephens Inc., 111 Center Street, Little Rock,
Arkansas 72201 (or at such other place as shall be agreed upon by the Placement Agent and the
Company), at 9:00 A.M., Central Standard Time, on November 15, 2007, unless another time and date
shall be agreed to by the Placement Agent and the Company. Subject to the terms and conditions
hereof, payment of the purchase price for the Shares shall be made by the Investors against
delivery of the Shares to the Investors. The Shares shall be registered in such names and shall be
in such denominations as are requested at least one business day prior to the date of closing by
written notice from the Placement Agent to the Company. The time (or times) at which such payment
and delivery are to be made is hereinafter sometimes called “the time of purchase.” Deliveries of
the documents described in Section 6 hereof with respect to the purchase and delivery of the Shares
shall be made at the office of Alston & Bird LLP at the time of purchase.

     3. Representations and Warranties of the Placement Agent. The Placement Agent represents and
warrants to and agrees with the Company that it has not distributed and will not, without the
Company’s consent, distribute, prior to the time of purchase, any free writing prospectus as
defined in Rule 433 under the Act other than the Issuer Free Writing Prospectuses listed on Exhibit
A or otherwise approved by the Company.

     4. Representations and Warranties of the Company. The Company represents and warrants to and
agrees with the Placement Agent that:

     (a) the Registration Statement has been declared effective under the Act; no stop order
of the Commission preventing or suspending the use of the Basic Prospectus, the Prospectus
Supplement or the Prospectus or suspending the effectiveness of the Registration Statement
has been issued and no proceedings for such purpose have been instituted or, to the
Company’s knowledge, are threatened by the Commission; the

3

 

Company was eligible to use Form S-3 on the date the Registration Statement was filed
and on the date hereof and all conditions to the use of Form S-3 have been satisfied; the
Company is not an ineligible issuer as such term is defined in Rule 405 under the Act; no
fundamental change (as referenced in Item 512 of the Commission’s Regulation S-K) to the
information set forth in the Registration Statement has occurred since the date of filing of
the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2006; the
Registration Statement as of the date of this Agreement meets, and the offering of the
Shares complies with, the requirements of Rule 415 under the Act; the Registration Statement
complied when it became effective, complies and will comply at the time of purchase, and the
Prospectus complied as of its date, complies and will comply at the time of purchase, in all
material respects with the requirements of the Act (including said Rule 415); the
Registration Statement did not at the time of effectiveness, does not and will not at the
time of purchase contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein not
misleading; the Prospectus did not as of its date, does not and will not at the time of
purchase contain an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading; the documents incorporated by
reference in the Registration Statement and the Prospectus, at the time they became
effective or were filed with the Commission, as amended to date, complied in all material
respects with the requirements of the Exchange Act and did not contain an untrue statement
of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading; and each Issuer Free Writing Prospectus, if any, did not as of
its date, does not and will not at the time of purchase contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein, in light of the circumstances under which they were made, not
misleading; provided, however, that the Company makes no representation or warranty with
respect to any statement contained in the Registration Statement, Prospectus or Disclosure
Package in reliance upon and in conformity with information concerning the Placement Agent
and furnished in writing by the Placement Agent to the Company expressly for use in the
Registration Statement, the Prospectus or the Disclosure Package;

     (b) the Company has not distributed and will not distribute, prior to the time of
purchase, any offering material in connection with the offering and sale of the Shares other
than the Prospectus and any Issuer Free Writing Prospectus reviewed and consented to by the
Placement Agent (which consent shall not be unreasonably withheld) or listed in Exhibit A
hereto; the Company is eligible to use Issuer Free Writing Prospectuses in connection with
the offering of the Shares pursuant to Rules 164 and 433 under the Act; each Issuer Free
Writing Prospectus, as of its issue date and at all subsequent times through the time of
purchase, as defined herein, did not, does not and will not contain any information that
conflicted, conflicts or will conflict with the information contained in the Registration
Statement, and if at any time following the issuance of an Issuer Free Writing Prospectus
there occurred or occurs an event or development as a result of which such Issuer Free
Writing Prospectus conflicted or would conflict with the information

4

 

contained in the Registration Statement, the Company has promptly notified or will
promptly notify the Placement Agent and has promptly amended or will promptly amend or
supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct
such conflict; each Issuer Free Writing Prospectus that the Company has filed, or is
required to file, pursuant to Rule 433(d) under the Act or that was prepared by or on behalf
of or used or referred to by the Company complies or will comply in all material respects
with the requirements of the Act; except for the Issuer Free Writing Prospectuses identified
in Exhibit A hereto and electronic road shows, if any, each furnished to you before first
use, the Company has not prepared, used or referred to, and will not, without your prior
written consent, prepare, use or refer to, any free writing prospectus, as such term is
defined in Rule 405 under the Act; and the Company has satisfied and will satisfy the
conditions of Rule 433 under the Act such that any electronic road show need not be filed
with the Commission;

     (c) the Company has been duly incorporated and is validly existing as a corporation in
good standing under the laws of the State of Delaware, with the power and authority to own,
lease and operate its properties and conduct its business as described in the Disclosure
Package and to execute and deliver this Agreement;

     (d) each subsidiary of the Company (collectively, the “Subsidiaries”) has been duly
organized and is validly existing and is in good standing under the laws of its jurisdiction
of organization, with the power and authority to own, lease and operate its properties and
conduct its business as described in the Disclosure Package; all of the issued shares of
capital stock of each Subsidiary that is a corporation have been duly authorized and validly
issued, are fully paid and are non-assessable and are owned directly or indirectly by the
Company, free and clear of all liens, encumbrances, equities or claims except for the liens
on shares of the Subsidiaries pursuant to that certain Credit Agreement among the Company,
the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent, dated as
of June 30, 2004, as amended; and all interests of each Subsidiary that is not a corporation
have been duly authorized and validly issued and are owned directly or indirectly by the
Company, free and clear of all liens, encumbrances, equities or claims except for the liens
on interests of the Subsidiaries pursuant to that certain Credit Agreement among the
Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent,
dated as of June 30, 2004, as amended; except where the failure (i) to be so organized,
validly existing and in good standing, (ii) to have such power and authority and (iii) to be
so duly authorized, validly issued, fully paid, nonassessable and owned would not,
individually or in the aggregate, (AA) have a material adverse effect on the condition,
financial or otherwise, or on the earnings, business, operations or prospects of the Company
and its Subsidiaries taken as a whole, whether or not arising in the ordinary course of
business, or (BB) have or reasonably be expected to have a material adverse effect on the
ability of the Company to consummate the transactions contemplated by this Agreement (a
“Material Adverse Effect”);

     (e) each of the Company and its Subsidiaries is duly qualified to do business as a
foreign corporation and is in good standing in each jurisdiction where the ownership

5

 

or leasing of its properties or the conduct of its business requires such
qualification, except where the failure to be so qualified and in good standing would not,
individually or in the aggregate, have a Material Adverse Effect;

     (f) all of the issued and outstanding shares of capital stock, including the Common
Stock, of the Company have been duly authorized and validly issued, are fully paid and
non-assessable, have been issued in compliance with all federal and state securities laws
and were not issued in violation of any preemptive right, resale right, right of first
refusal or similar right; and as of the date set forth therein, the Company shall have an
authorized and outstanding capitalization as set forth in the Prospectus under the heading
“Capitalization” (subject to the subsequent issuance of shares of Common Stock upon
conversion of existing convertible securities and exercise by employees of existing stock
options disclosed as outstanding in the Disclosure Package and the subsequent grant to
employees, under the existing stock-based compensation plans of the Company and its
Subsidiaries described in the Prospectus (the “Company Stock Plans”), of stock options and
            shares of restricted stock that are not exercisable or vested, as the case may be, during
the Lock-up Period (as such term is defined in Section 5(j) hereof));

     (g) the Shares have been duly authorized and, when issued and paid for in accordance
with the terms of this Agreement, will be validly issued, fully paid and non-assessable and
will be free of any statutory or contractual preemptive rights, resale rights, rights of
first refusal or similar rights;

     (h) the authorized capital stock of the Company, including the Common Stock, conforms
in all material respects to the description thereof contained in the Registration Statement
and the Prospectus;

     (i) this Agreement has been duly authorized, executed and delivered by the Company;

     (j) neither the Company nor any of its Subsidiaries is in breach or violation of or in
default under (nor has any event occurred which with notice, lapse of time or both would
result in any breach or violation of, constitute a default under or give the holder of any
indebtedness (or a person acting on such holder’s behalf) the right to require the
repurchase, redemption or repayment of all or a part of such indebtedness under) its
certificate of incorporation or bylaws or corresponding organizational documents, as the
case may be, or any indenture, mortgage, deed of trust, bank loan or credit agreement or
other evidence of indebtedness, or any license, lease, contract or other agreement or
instrument to which it is a party or by which it or any of its properties may be bound or
affected, except where such breach, violation or default (other than a breach or violation
of, or default under, the Company’s certificate of incorporation or bylaws or any of the
Subsidiaries’ corresponding organizational documents) would not, individually or in the
aggregate, have a Material Adverse Effect; and the execution, delivery and performance of
this Agreement and the consummation of the transactions contemplated hereby will not
conflict with, result in any breach or violation of or constitute a default under (nor
constitute any event which with notice, lapse of time or both would result in any breach

6

 

or violation of or constitute a default under or give the holder of any indebtedness
(or a person acting on such holder’s behalf) the right to require the repurchase, redemption
or repayment of all or a part of such indebtedness under) the certificate of incorporation
or bylaws of the Company or the corresponding organizational documents of the Subsidiaries,
or any indenture, mortgage, deed of trust, bank loan or credit agreement or other evidence
of indebtedness, or any license, lease, contract or other agreement or instrument to which
the Company or any Subsidiary is a party or by which any of them or any of its properties
may be bound or affected, or any federal, state, local or foreign law, regulation or rule or
any decree, judgment or order applicable to the Company or any Subsidiary, except where such
breach, violation or default (other than a breach or violation of, or default under, the
Company’s certificate of incorporation or bylaws or any of the Subsidiaries’ corresponding
organizational documents) would not, individually or in the aggregate, have a Material
Adverse Effect or a material adverse effect on the transactions contemplated by this
Agreement;

     (k) no approval, authorization, consent or order of or filing with any federal, state,
local or foreign governmental or regulatory commission, board, body, authority or agency or
of or with the NASDAQ Global Market is required in connection with the sale by the Company
of the Shares or the consummation by the Company of the transactions contemplated hereby
other than (i) registration under the Act of the offer and sale of the Shares, (ii) listing
of the Shares on the NASDAQ Global Market, (iii) approval of the offering terms and
arrangements by FINRA, (iv) any necessary qualification under the securities or blue sky
laws of the various jurisdictions in which the Shares are being offered, (v) such others as
have been obtained or taken and are in full force and effect and (vi) such notices or
filings that would not individually or in the aggregate have a Material Adverse Effect;

     (l) no approval of the stockholders of the Company is required under the laws of the
State of Delaware or the rules and regulations of The Nasdaq Stock Market (including Rule
4350 of the Nasdaq Marketplace Rules) in connection with the sale by the Company of the
Shares or the consummation by the Company of the transactions contemplated hereby;

     (m) except as disclosed in the Disclosure Package, (i) no person has the right,
contractual or otherwise, to cause the Company to issue or sell to it any shares of Common
Stock or other securities of the Company, (ii) no person has any preemptive rights, resale
rights, rights of first refusal or other rights to purchase any shares of Common Stock or
other securities of the Company, and (iii) except as provided herein, no person has the
right to act as an underwriter, placement agent or financial advisor to the Company or to
receive a brokerage commission or a finder’s fee in connection with the offer and sale of
the Shares, in the case of each of the foregoing clauses (i), (ii) and (iii), whether as a
result of the filing or effectiveness of the Registration Statement or the sale of the
Shares as contemplated thereby or otherwise and except, in each case, for such rights as
have been duly and validly satisfied or waived; except as disclosed in the Disclosure
Package, no person has the right, contractual or otherwise, to cause the Company to register
under the Act any shares of Common Stock or other securities of the

7

 

Company, or to include any such shares or other securities in the Registration
Statement or the offering contemplated thereby, whether as a result of the filing or
effectiveness of the Registration Statement or the sale of the Shares as contemplated
thereby or otherwise other than such rights as have been duly and validly satisfied or
waived;

     (n) except as described in the Disclosure Package, the Company has not sold, issued or
distributed any shares of Common Stock during the six-month period preceding the date
hereof, including any sales pursuant to Rule 144A or Regulations D or S under the Act, other
than shares issued pursuant to the Company Stock Plans;

     (o) each of the Company and its Subsidiaries has all licenses, authorizations, consents
and approvals and has made all filings required under any federal, state, local or foreign
law, regulation or rule, and has obtained all authorizations, consents and approvals from
other persons, necessary in order to conduct its business as described in the Disclosure
Package except where such failure to do so would not, individually or in the aggregate, have
a Material Adverse Effect; and neither the Company nor its Subsidiaries is in violation of,
or in default under, or has received notice of any proceedings relating to revocation or
modification of, any such license, authorization, consent or approval or any federal, state,
local or foreign law, regulation or rule or any decree, order or judgment applicable to the
Company or its Subsidiaries, except where such violation, default, revocation or
modification would not, individually or in the aggregate, have a Material Adverse Effect;

     (p) except as disclosed in the Disclosure Package, there are no actions, suits, claims,
investigations or proceedings pending or, to the Company’s knowledge, threatened, nor is
there, to the Company’s knowledge, any reasonable basis for the assertion of any actions,
suits, claims, investigations or proceedings, to which the Company or any of its
Subsidiaries or any of their directors or officers is or would be a party or of which any of
their properties is or would be subject, at law or in equity, before or by any federal,
state, local or foreign governmental or regulatory commission, board, body, authority or
agency, except any such action, suit, claim, investigation or proceeding which would not
result in a judgment, decree or order having, individually or in the aggregate, a Material
Adverse Effect;

     (q) Each of BDO Seidman, LLP, PricewaterhouseCoopers LLP and Bonadio & Co., LLP, each
of whose report on the financial statements of the Company is filed with the Commission as
part of the Registration Statement and the Prospectus, is an independent registered public
accounting firm as required by the Act;

     (r) the audited financial statements included or incorporated by reference in the
Registration Statement and included or incorporated by reference in the Disclosure Package,
together with the related notes and schedules, present fairly in all material respects the
consolidated financial position of the Company as of the dates indicated and the results of
operations and cash flows of the Company at the dates and for the periods specified,
subject, in the case of unaudited interim statements, to normal, year-end audit adjustments,
and have been prepared in compliance with the requirements of the Act and

8

 

in conformity with generally accepted accounting principles in the United States
applied on a consistent basis during the periods involved, except (i) as may be otherwise
specified in such financial statements or the notes thereto, or (ii) in the case of
unaudited interim statements, to the extent they may exclude footnotes or may be condensed
or summary statements; the other financial data of the Company contained in the Registration
Statement and the Disclosure Package are accurately presented and prepared on a basis
consistent with the financial statements and books and records of the Company; there are no
financial statements (historical or pro forma) that are required by the Act to be included
in the Registration Statement, the Disclosure Package and the Prospectus that are not
included as required by the Act; and the Company does not have any material liabilities or
obligations, direct or contingent, not disclosed in the Registration Statement or the
Disclosure Package;

     (s) except as described in the Disclosure Package, with respect to stock options and
            shares of restricted stock granted to employees pursuant to the Company Stock Plans, (i)
each stock option designated by the Company at the time of grant as an “incentive stock
option” under Section 422 of the Internal Revenue Code of 1986, as amended (the “Internal
Revenue Code”), so qualifies, (ii) each grant of a stock option or of shares of restricted
stock was duly authorized no later than the date on which such grant was by its terms to be
effective (the “Grant Date”) by all necessary corporate action, including, as applicable,
approval by the board of directors of the Company (or a duly constituted and authorized
committee thereof) and any required stockholder approval, and the award agreement governing
such grant (if any) was duly executed and delivered by each party thereto, (iii) each such
grant was made in accordance with the terms of the Company Stock Plans, the Exchange Act and
all other applicable laws and regulatory rules or requirements, including the rules of the
NASDAQ Global Market and any other exchange on which Company securities are traded, (iv) the
per share exercise price of each stock option was equal to or greater than the fair market
value of a share of Common Stock on the applicable Grant Date and (v) each such grant was
properly accounted for in accordance with generally accepted accounting principles in the
United States in the financial statements (including the related notes) of the Company and
disclosed in the Company’s filings with the Commission in accordance with the Exchange Act
and all other applicable laws. The Company has not knowingly granted, and there is and has
been no policy or practice of the Company of granting, stock options or shares of restricted
stock prior to, or otherwise coordinating the grant of stock options or shares of restricted
stock with, the release or other public announcements of material information regarding the
Company or its Subsidiaries or their results of operations or prospects;

     (t) subsequent to the respective dates as of which information is given in the
Disclosure Package, there has not been (i) any event that has had, or that reasonably could
be expected to have, a Material Adverse Effect, (ii) any transaction which is material to
the Company or any Subsidiary, except obligations and liabilities incurred in the ordinary
course of business consistent with past practice, (iii) any obligation or liability, direct
or contingent (including any off-balance sheet obligations), incurred by the Company or any
Subsidiary, which is material to the Company, except obligations

9

 

and liabilities incurred in the ordinary course of business consistent with past
practice, (iv) any change in the capital stock of the Company or any Subsidiary (except for
the issuance of shares of Common Stock upon conversion of existing convertible securities
and exercise by employees of existing stock options disclosed as outstanding in the
Disclosure Package and the grant to employees, under the Company Stock Plans, of stock
options and shares of restricted stock that are not exercisable or vested, as the case may
be, during the Lock-up Period (as such term is defined in Section 5(j) hereof)) or (v) any
dividend or distribution of any kind declared, paid or made on the capital stock of the
Company;

     (u) neither the Company nor any Subsidiary is, or will be after giving effect to the
offering and sale of the Shares and the application of the net proceeds thereof as described
in the Disclosure Package, an “investment company” or an entity “controlled” by an
“investment company,” as such terms are defined in the Investment Company Act of 1940, as
amended (the “Investment Company Act”). Neither the Company nor any Subsidiary is a
“passive foreign investment company” or a “controlled foreign corporation” as such terms are
defined in the Internal Revenue Code;

     (v) except as described in the Disclosure Package, the Company and its Subsidiaries
have good title to all material property (real and personal) described in the Disclosure
Package as being owned by each of them, free and clear of all liens, claims, security
interests or other encumbrances, or subject only to liens, claims, security interests or
other encumbrances that do not individually or in the aggregate materially affect the value
of such property or materially interfere with the use of such property by the Company and
its Subsidiaries; and all the property described in the Disclosure Package as being held
under lease by the Company and its Subsidiaries is held thereby under valid, subsisting and
enforceable leases except as would not result in a Material Adverse Effect;

     (w) except as described in the Disclosure Package, the Company and its Subsidiaries
own, or have obtained valid and enforceable licenses for, or other rights to use, all
inventions, patent applications, patents, trademarks (both registered and unregistered),
tradenames, copyrights, trade secrets and other intellectual property (collectively,
“Intellectual Property”) described in the Disclosure Package as being owned or licensed by
them, except where such failure to do so would not have a Material Adverse Effect; to the
Company’s knowledge and except as described in the Disclosure Package, the Company and its
Subsidiaries own, or have obtained valid and enforceable licenses for or other rights to
use, all Intellectual Property used in, or necessary for the conduct of, their current
business as described in the Disclosure Package except as would not result in a Material
Adverse Effect; to the Company’s knowledge, there is no pending or threatened action, suit,
proceeding or written claim by others that the Company or any of its Subsidiaries infringes
any Intellectual Property rights of others, except as would not result in a Material
Adverse Effect; to the Company’s knowledge, the conduct of its current business as described
in the Disclosure Package does not infringe any issued patents or registered trademarks of
others and neither the Company nor any of its Subsidiaries has knowingly misappropriated any
trade secrets of others, except as would

10

 

result in a Material Adverse Effect; and to the Company’s knowledge, none of the
technology used by the Company or any of its Subsidiaries as described in the Disclosure
Package has been obtained or is being used by the Company or any Subsidiary in violation of
any contractual obligation binding on the Company or any Subsidiary or, to the Company’s
knowledge, upon any of its officers, directors or employees except as would not result in a
Material Adverse Effect;

     (x) Each material contract, agreement and license listed as an exhibit to or described
in the Registration Statement or the Disclosure Package to which the Company or any of its
Subsidiaries is bound is legal, valid, binding, enforceable and in full force and effect
against the Company or such Subsidiary, except to the extent such enforceability is subject
to (i) laws of general application relating to bankruptcy, insolvency, moratorium and the
relief of debtors and (ii) the availability of specific performance, injunctive relief and
other equitable remedies; neither the Company nor any of its Subsidiaries is in material
breach or default with respect to any such contract, agreement and license; to the Company’s
knowledge, no event has occurred which with notice or lapse of time would constitute a
material breach or default, or permit termination, modification, or acceleration, under any
such contract, agreement or license; and neither the Company nor any of its Subsidiaries has
repudiated any material provision of any such contract, agreement or license;

     (y) the Company is not engaged in any unfair labor practice; except for matters which
would not, individually or in the aggregate, have a Material Adverse Effect, (i) there is
(A) no unfair labor practice complaint pending or, to the Company’s knowledge, threatened
against the Company or any Subsidiary before the National Labor Relations Board, and no
grievance or arbitration proceeding arising out of or under collective bargaining agreements
is pending or, to the Company’s knowledge, threatened, (B) no strike, labor dispute,
slowdown or stoppage pending or, to the Company’s knowledge, threatened against the Company
or any Subsidiary and (C) no union representation dispute currently existing concerning the
employees of the Company or any Subsidiary, and (ii) to the Company’s knowledge, (A) no
union organizing activities are currently taking place concerning the employees of the
Company or any Subsidiary and (B) there has been no violation of any federal, state, local
or foreign law relating to discrimination in the hiring, promotion or pay of employees, any
applicable wage or hour laws or any provision of the Employee Retirement Income Security Act
of 1974 or the rules and regulations promulgated thereunder concerning the employees of the
Company, except in the cases of clauses (i) and (ii) for such actions which would not,
individually or in the aggregate, have a Material Adverse Effect;

     (z) the Company and its Subsidiaries and their properties, assets and operations are in
compliance with, and hold all permits, authorizations and approvals required to conduct
their business under, Environmental Laws (as defined below), except to the extent that
failure to so comply or to hold such permits, authorizations or approvals would not,
individually or in the aggregate, have a Material Adverse Effect; there are no past, present
or, to the Company’s knowledge, reasonably anticipated future events, conditions,
circumstances, activities, practices, actions, omissions or plans that could

11

 

reasonably be expected to give rise to any material costs or liabilities to the Company
or any Subsidiary under, or to interfere with or prevent compliance by the Company or any
Subsidiary with, Environmental Laws, except as would not, individually or in the aggregate,
have a Material Adverse Effect; neither the Company nor any Subsidiary (i) is the subject of
any investigation, (ii) has received any notice or claim, (iii) is a party to or affected by
any pending or threatened action, suit or proceeding, (iv) is bound by any judgment, decree
or order or (v) has entered into any agreement, in each case relating to any alleged
violation of any Environmental Law or any actual or alleged release or threatened release or
cleanup at any location of any Hazardous Materials (as defined below) except as would not,
individually or in the aggregate, have a Material Adverse Effect (as used herein,
“Environmental Law” means any federal, state, local or foreign law, statute, ordinance,
rule, regulation, order, decree, judgment, injunction, permit, license, authorization or
other binding requirement, or common law applicable to the Company or any Subsidiary
relating to health, safety or the protection, cleanup or restoration of the environment or
natural resources, including those relating to the distribution, processing, generation,
treatment, storage, disposal, transportation, other handling or release or threatened
release of Hazardous Materials, and “Hazardous Materials” means any material (including,
without limitation, pollutants, contaminants, hazardous or toxic substances or wastes) that
is regulated by or may give rise to liability under any Environmental Law);

     (aa) all material tax returns required to be filed by the Company and its Subsidiaries
have been filed and all material taxes and other assessments of a similar nature (whether
imposed directly or through withholding), including any interest, additions to tax or
penalties applicable thereto, due or claimed to be due have been paid or accrued,
other than those being contested in good faith and which, if resolved unfavorably to the
Company, would not result in a Material Adverse Effect;

     (bb) the Company and its Subsidiaries maintain insurance covering their respective
properties, operations, personnel and businesses as is reasonably appropriate; such
insurance insures against such losses and risks to an extent which is customary for the
business and the locations in which the Company and its Subsidiaries are engaged; and all
such insurance is fully in force on the date hereof and the Company has no reason to believe
that such insurance will not be fully in force at the time of purchase;

     (cc) except as otherwise disclosed in the Disclosure Package, the Company maintains (i)
effective internal control over financial reporting as defined in Rule 13a-15 under the
Exchange Act and (ii) a system of internal accounting controls sufficient to provide
reasonable assurance that (w) transactions are executed in accordance with management’s
general or specific authorizations; (x) transactions are recorded as necessary to permit
preparation of financial statements in conformity with generally accepted accounting
principles and to maintain asset accountability; (y) access to assets is permitted only in
accordance with management’s general or specific authorization; and (z) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and
appropriate action is taken with respect to any differences;

12

 

     (dd) except as otherwise disclosed in the Disclosure Package, since the end of the
Company’s most recent audited fiscal year, there has been (i) no material weakness in the
design or operation of the Company’s internal control over financial reporting (whether or
not remediated) which is reasonably likely to adversely affect the Company’s ability to
record, process, summarize and report financial information and (ii) no change in the
Company’s internal control over financial reporting that has materially adversely affected,
or is reasonably likely to materially adversely affect, the Company’s internal control over
financial reporting;

     (ee) the Company has established and maintains disclosure controls and procedures as
such term is defined in Rule 13a-15(e) under the Exchange Act; the principal executive
officer and the principal financial officer of the Company have made all certifications
required by the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) and any related rules
and regulations promulgated thereunder by the Commission, and the statements contained in
any such certification are complete and correct; and the Company is otherwise in compliance
in all material respects with all applicable provisions of the Sarbanes-Oxley Act;

     (ff) neither the Company nor any of its Subsidiaries nor, to the knowledge of the
Company, any director, officer, agent, employee or affiliate of the Company or any of its
Subsidiaries is aware of or has taken any action, directly or indirectly, that would result
in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and
the rules and regulations thereunder (the “FCPA”), including, without limitation, making use
of the mails or any means or instrumentality of interstate commerce corruptly in furtherance
of an offer, payment, promise to pay or authorization of the payment of any money, or other
property, gift, promise to give, or authorization of the giving of anything of value to any
“foreign official” (as such term is defined in the FCPA) or any foreign political party or
official thereof or any candidate for foreign political office, in contravention of the
FCPA; and the Company, its Subsidiaries and, to the knowledge of the Company, its affiliates
have conducted their businesses in compliance with the FCPA and have instituted and maintain
policies and procedures designed to ensure, and which are reasonably expected to continue to
ensure, continued compliance therewith;

     (gg) the operations of the Company and its Subsidiaries are and have been conducted at
all times in compliance with applicable financial recordkeeping and reporting requirements
and the money laundering statutes and the rules and regulations thereunder and any related
or similar rules, regulations or guidelines, issued, administered or enforced by any
governmental agency (collectively, the “Money Laundering Laws”) and no action, suit or
proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company or any of its Subsidiaries with respect to the Money
Laundering Laws is pending or, to the best knowledge of the Company, threatened;

     (hh) Neither the Company nor any of its Subsidiaries nor, to the knowledge of the
Company, any director, officer, agent, employee or affiliate of the Company or any of

13

 

its Subsidiaries is currently subject to any sanctions administered by the Office of
Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will not
directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise
make available such proceeds to any Subsidiary, joint venture partner or other person or
entity, for the purpose of financing the activities of any person currently subject to any
U.S. sanctions administered by OFAC; and

     (ii) neither the Company nor, to the Company’s knowledge, any of its directors,
officers, affiliates or controlling persons has taken, directly or indirectly, any action
designed, or which has constituted or might reasonably be expected to cause or result in,
under the Exchange Act or otherwise, the stabilization or manipulation of the price of any
security of the Company to facilitate the sale or resale of the Shares.

     In addition, any certificate signed by any officer of the Company and delivered to the
Placement Agent or counsel for the Placement Agent in connection with the closing of the sale of
the Shares shall be deemed to be a representation and warranty by the Company to the Placement
Agent as to the matters covered thereby.

     5. Certain Covenants of the Company. The Company hereby agrees:

     (a) to furnish to the Placement Agent in Little Rock, Arkansas, from time to time, as
many copies of the Registration Statement, the Disclosure Package and the Prospectus (or of
the Prospectus as amended or supplemented), as the Placement Agent may reasonably request;

     (b) until the time of purchase, to advise the Placement Agent promptly, confirming such
advice in writing, of any request by the Commission for amendments or supplements to the
Registration Statement or the Prospectus or for additional information with respect thereto,
or of notice of the institution of proceedings for, or the entry of a stop order, suspending
the effectiveness of the Registration Statement and, if the Commission should enter a stop
order suspending the effectiveness of the Registration Statement, to promptly use its
commercially reasonable efforts to obtain the lifting or removal of such order; to advise
the Placement Agent promptly of any proposal to amend or supplement the Registration
Statement or the Prospectus, including by filing any documents that would be incorporated by
reference therein, and to provide the Placement Agent and its counsel copies of any such
documents for review and comment a reasonable amount of time prior to any proposed filing
and to file no such amendment or supplement to which the Placement Agent shall reasonably
object;

     (c) until the time of purchase, to advise the Placement Agent promptly of the happening
of any event which might require the making of any change in the Disclosure Package or the
Prospectus then being used so that the Disclosure Package or the Prospectus would not
include an untrue statement of material fact or omit to state a material fact necessary to
make the statements therein, in the light of the circumstances under which they are made,
not misleading, and, prior to the time of purchase, if deemed necessary or appropriate by
the Company or the Placement Agent, and subject to Section

14

 

5(d) hereof, to prepare and furnish, at the Company’s expense, to the Placement Agent
promptly such amendments or supplements to the Registration Statement, the Disclosure
Package or such Prospectus as may be necessary to reflect any such change;

     (d) not to make, without the prior approval of the Placement Agent, and the Placement
Agent agrees not to make, without the prior approval of the Company, which approvals shall
not be unreasonably withheld, any offer relating to the Shares that would constitute a “free
writing prospectus” (as defined in Rule 405 of the Act) required to be filed with the
Commission or retained by the Company under Rule 433 of the Act (any such free writing
prospectus approved by the Placement Agent or the Company being hereinafter referred to as a
“Permitted Free Writing Prospectus”), and to comply with the requirements of Rules 164 and
433 under the Act applicable to free writing prospectuses, including in respect of timely
filing with the Commission, legending and recordkeeping;

     (e) to endeavor to qualify the Shares for offer and sale under the securities or blue
sky laws of such jurisdictions as the Placement Agent reasonably shall request;

     (f) to make generally available to its security holders, and to deliver to the
Placement Agent, an earnings statement of the Company (which will satisfy the provisions of
Section 11(a) of the Act) covering a period of twelve months beginning after the effective
date of the Registration Statement (as defined in Rule 158(c) under the Act) as soon as is
reasonably practicable after the termination of such twelve-month period;

     (g) to comply with all the undertakings contained in the Registration Statement;

     (h) whether or not the transactions contemplated by this Agreement are consummated or
this Agreement is terminated, to reimburse the Placement Agent promptly upon request for all
out of pocket expenses incurred by the Placement Agent in the performance of its duties and
obligations hereunder, including its travel expenses and the reasonable fees and
disbursements of its outside legal counsel and other experts;

     (i) whether or not the transactions contemplated by this Agreement are consummated or
this Agreement is terminated, to pay or cause to be paid all of the Company’s costs,
expenses, fees and taxes in connection with (i) this Agreement and any of the transactions
contemplated hereby, (ii) the preparation and filing of the Registration Statement, the
Basic Prospectus, each Prospectus Supplement, the Prospectus, any electronic road show and
any amendments or supplements thereto and each Issuer Free Writing Prospectus, and the
printing and furnishing of copies of each thereof to the Placement Agent and the Investors
(including costs of mailing and shipment), (iii) the producing, word processing and/or
printing of this Agreement and the reproduction and/or printing and furnishing of copies of
each thereof to the Placement Agent and the Investors, (iv) the fee payable to FINRA related
to its review of the offering terms and arrangements, (v) any fee payable to The Nasdaq
Stock Market for listing the Shares on the NASDAQ Global Market, (vi) the qualification of
the Shares for offering and sale

15

 

under state or foreign securities or blue sky laws and the determination of their
eligibility for investment under state or foreign law as aforesaid and the printing and
furnishing of copies of any blue sky surveys or legal investment surveys to the Placement
Agent and to dealers, (vii) the expenses of the Company relating to investor presentations
on any “road show” undertaken in connection with the marketing of the offering of the
Shares, including, without limitation, expenses associated with the production of road show
slides and graphics, fees and expenses of any consultants engaged in connection with the
road show presentations with the prior approval of the Company, travel and lodging expenses
of the employees and representatives of the Company and any such consultants, and the cost
of any aircraft chartered with the approval of the Company in connection with the road show,
(viii) the fees and disbursements of any transfer agent or registrar for the Shares, and
(ix) the performance of the Company’s other obligations hereunder;

     (j) not to directly or indirectly sell, offer, contract or grant any option to sell,
pledge or otherwise dispose of or transfer (or enter into any transaction which is designed
to, or might reasonably be expected to, result in the disposition or transfer of) any shares
of Common Stock, options to acquire shares of Common Stock or securities exchangeable or
exercisable for or convertible into shares of Common Stock or other rights to purchase
Common Stock or any other securities of the Company that are substantially similar to Common
Stock, or file or cause to be declared effective a registration statement under the Act
(except for registration statements on Form S-8) relating to the offer and sale of any
            shares of Common Stock or securities exercisable or exchangeable for or convertible into
            shares of Common Stock or other rights to purchase Common Stock or any other securities of
the Company that are substantially similar to Common Stock, or publicly announce any
intention to do any of the foregoing, for a period of 75 days after the date hereof (the
“Lock-Up Period”), without the prior written consent of the Placement Agent, except for (i)
the Company’s sale of the Shares as contemplated hereunder, (ii) issuances of shares of
Common Stock upon conversion of existing convertible securities and exercise by employees of
existing stock options disclosed as outstanding in the Disclosure Package, (iii) the grant
to employees, under the Company Stock Plans, of stock options and shares of restricted stock
that are not exercisable or vested, as the case may be, during the Lock-Up Period, and (iv)
sales of shares of Common Stock by the individuals in the amounts set forth on Exhibit B;
provided, however, that if (i) the Company issues an earnings release or material news, or a
material event relating to the Company occurs, during the last 17 days of the Lock-Up
Period, or (ii) prior to the expiration of the Lock-Up Period, the Company announces that it
will release earnings results during the 16-day period beginning on the last day of the
Lock-Up Period, the restrictions imposed hereby shall continue to apply until the expiration
of the 18-day period beginning on the issuance of the earnings release or the occurrence of
the material news or material event, unless the Placement Agent waives, in writing, such
extension; and the Company agrees to provide notice to the Placement Agent of any event that
would result in an extension of the Lock-Up Period;

     (k) to (i) as soon as practicable following execution of this Agreement, (A) prepare a
final term sheet related to the offering of the Shares containing only information that
describes the final terms of the offering in a form reasonably acceptable

16

 

to the Placement Agent and to file such final term sheet within the period required by
Rule 433 under the Act and (B) issue a press release reasonably acceptable to the Placement
Agent disclosing all material terms of the transactions contemplated hereby, and (ii) on or
before the first business day following execution of this Agreement, (Y) file the Prospectus
Supplement with the Commission pursuant to Rule 424(b) under the Act and (Z) file a Current
Report on Form 8-K with the Commission describing the terms of the transactions contemplated
by this Agreement and including as exhibits to such Current Report on Form 8-K this
Agreement and other documents required by the Exchange Act to be filed as exhibits thereto;

     (l) to maintain a transfer agent and, if necessary under the laws of the State of
Delaware, a registrar for the Common Stock; and

     (m) if, at the time this Agreement is executed and delivered, it is necessary for a
post-effective amendment to the Registration Statement to be declared effective before the
offering of the Shares may commence, to use commercially reasonable efforts to cause such
post-effective amendment to become effective as soon as possible and to advise the Placement
Agent promptly and, if requested by the Placement Agent, to confirm such advice in writing,
when such post-effective amendment has become effective.

     6. Conditions of Placement Agent’s Obligations. The obligations of the Placement Agent
hereunder are subject to the accuracy of the representations and warranties of the Company on the
date hereof and at the time of purchase, to the performance by the Company of its obligations
hereunder and to the following additional conditions precedent:

     (a) the Company shall furnish to the Placement Agent at the time of purchase an opinion
of Harter Secrest & Emery LLP, counsel to the Company, addressed to the Placement Agent and
dated the time of purchase, in the form heretofore approved by the Placement Agent and its
outside legal counsel;

     (b) the Placement Agent shall have received from BDO Seidman, LLP letters dated,
respectively, the date of this Agreement and the time of purchase, and addressed to the
Placement Agent in the forms heretofore approved by the Placement Agent;

     (c) the Company shall have furnished to the Placement Agent a lock-up agreement in the
form of Exhibit C hereto from each director and executive officer of the Company, except for
sales of shares of Common Stock by the individuals in the amounts set forth on Exhibit B,
and such agreements shall be in full force and effect at the time of purchase;

     (d) the Placement Agent shall have received at the time of purchase an opinion of
Alston & Bird LLP, dated the time of purchase, in form and substance satisfactory to the
Placement Agent;

17

 

     (e) prior to the time of purchase, no Prospectus or amendment or supplement to the
Registration Statement or the Prospectus, including documents deemed to be incorporated by
reference therein, shall have been filed to which the Placement Agent reasonably shall have
objected;

     (f) prior to the time of purchase, (i) no stop order with respect to the effectiveness
of the Registration Statement shall have been issued under the Act or proceedings initiated
under Section 8(d) or 8(e) of the Act; (ii) the Registration Statement shall not contain an
untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading; (iii) the Disclosure
Package shall not contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in the light
of the circumstances under which they are made, not misleading; (iv) FINRA shall have
confirmed that is has no objection with regard to the fairness and reasonableness of the
offering terms and conditions; and (v) all filings required by Rule 424, Rule 430A, Rule
430B, Rule 430C and Rule 433 under the Act shall have been timely made;

     (g) subsequent to the execution and delivery of this Agreement and prior to the time of
purchase, there shall not have been (i) any event that has had, or that reasonably could be
expected to have, a Material Adverse Effect, (ii) any transaction which is material to the
Company or any Subsidiary and not disclosed in the Disclosure Package, except obligations
and liabilities incurred in the ordinary course of business consistent with past practice,
(iii) any obligation or liability, direct or contingent (including any off-balance sheet
obligations), incurred by the Company or any Subsidiary, which is material to the Company
and its Subsidiaries taken as a whole, except obligations and liabilities incurred in the
ordinary course of business consistent with past practice, (iv) any change in the capital
stock of the Company or any Subsidiary (except for the issuance of shares of Common Stock
upon conversion of existing convertible securities and exercise by employees of existing
stock options disclosed as outstanding in the Disclosure Package and the grant to employees,
under the Company Stock Plans, of stock options and shares of restricted stock that are not
exercisable or vested, as the case may be, during the Lock-up Period) or (v) any dividend or
distribution of any kind declared, paid or made on the capital stock of the Company that, in
each case, makes it, in the judgment of the Placement Agent, impracticable or inadvisable to
market the Shares on the terms and in the manner contemplated in the Prospectus;

     (h) the Company shall have delivered to the Placement Agent a certificate of its Chief
Executive Officer and its Chief Financial Officer in the form attached as Exhibit D hereto;
and

     (i) the Company shall have furnished to the Placement Agent such other documents and
certificates as the Placement Agent or its counsel may reasonably request;

     7. Effective Date of Agreement; Termination. This Agreement shall become effective when the
parties hereto have executed and delivered this Agreement.

18

 

     The obligations of the Placement Agent hereunder shall be subject to termination in the
absolute discretion of the Placement Agent if, at any time prior to the time of purchase, there
shall have occurred: (i) a suspension or material limitation in trading in securities generally on
the NASDAQ Global Market; (ii) a suspension or material limitation in trading in the Company’s
securities on the NASDAQ Global Market; (iii) a general moratorium on commercial banking activities
declared by either federal, New York or Delaware state authorities or a material disruption in
commercial banking or securities settlement or clearance services in the United States; (iv) an
outbreak or escalation of hostilities or acts of terrorism involving the United States or a
declaration by the United States of a national emergency or war; or (v) any other calamity or
crisis or any change in financial, political or economic conditions in the United States or
elsewhere, if the effect of any such event specified in clause (iv) or (v) in the Placement Agent’s
judgment makes it impracticable or inadvisable to proceed with the public offering or the delivery
of the Shares on the terms and in the manner contemplated in the Registration Statement, the
Disclosure Package and the Prospectus.

     If the sale of the Shares, as contemplated by this Agreement, is not carried out for any
reason permitted under this Agreement or if such sale is not carried out because the Company shall
be unable to comply with any of the terms of this Agreement, the Company shall not be under any
obligation or liability under this Agreement (except to the extent provided in Sections 5 and 8
hereof) and the Placement Agent shall be under no obligation or liability to the Company under this
Agreement (except to the extent provided in Section 8 hereof).

     8. Indemnification.

     (a) The Company agrees (i) to indemnify, defend and hold harmless the Placement Agent,
its directors, officers, employees and representatives, and each person, if any, who
controls the Placement Agent within the meaning of Section 15 of the Act or Section 20 of
the Exchange Act, and the successors and assigns of all of the foregoing persons, from and
against any loss, claim, damage, liability or expense (or actions in respect thereof as
contemplated below) (including the reasonable costs of investigation and defense) to which
the Placement Agent or any such person may become subject, insofar as such loss, claim,
damage, liability or expense (or actions in respect thereof as contemplated below) arises
out of or is based (A) upon any untrue statement or alleged untrue statement of a material
fact contained in the Registration Statement or any amendment thereto, including any
information deemed to be a part thereof pursuant to Rule 430A, Rule 430B or Rule 430C under
the Act, or the omission or alleged omission therefrom of a material fact required to be
stated therein or necessary to make the statements therein not misleading, (B) upon any
untrue statement or alleged untrue statement of a material fact contained in the Disclosure
Package, any Issuer Free Writing Prospectus, the Prospectus or any amendment or supplement
thereto or the omission or alleged omission therefrom of a material fact necessary in order
to make the statements therein, in the light of the circumstances under which they were
made, not misleading, or (C) in whole or in part upon any act or failure to act or alleged
act or failure to act by the Placement Agent in reliance upon (A) or (B), and in connection
with or relating in any manner to the Shares or the offering contemplated hereby, and which
is included as part

19

 

of or referred to in any loss, claim, damage, liability, expense or action arising out
of or based upon any matter covered by clause (A) or (B) above, and (ii) to reimburse the
Placement Agent, its officers, directors, employees and representatives and each such
controlling person for any and all expenses (including the fees and disbursements of counsel
chosen by the Placement Agent) as such expenses are reasonably incurred by the Placement
Agent or its officers, directors, employees and representatives or such controlling person
in connection with investigating, defending, settling, compromising or paying any such loss,
claim, damage, liability, expense or action; provided, however, that the foregoing indemnity
agreement shall not apply to any loss, claim, damage, liability, expense or action to the
extent, but only to the extent, arising out of or based upon any untrue statement or alleged
untrue statement or omission or alleged omission made in reliance upon and in conformity
with written information furnished to the Company by the Placement Agent expressly for use
in the Registration Statement, the Disclosure Package, any Issuer Free Writing Prospectus,
or the Prospectus (or any amendment or supplement thereto); and provided further, that such
indemnity agreement shall not apply to any loss, claim, damage, liability, expense or action
to the extent arising out of or based upon an untrue statement or omission of a material
fact contained in the Disclosure Package or Prospectus which was corrected in a supplement
to the Disclosure Package or Prospectus that was provided to the Placement Agent prior to
the distribution by it of a term sheet that reflects the pricing and other final terms of
the offering contemplated hereby. The indemnity agreement set forth in this Section 8(a)
shall be in addition to any liabilities that the Company may otherwise have.

     (b) The Placement Agent agrees to indemnify and hold harmless the Company, each of its
directors, officers, employees and representatives, and each person, if any, who controls
the Company within the meaning of Section 15 of the Act or Section 20 of the Exchange Act,
against any loss, claim, damage, liability or expense (or actions in respect thereof as
contemplated below) (including the reasonable cost of investigation and defense) to which
the Company or any such director, officer, employee, representative or controlling person
may become subject, insofar as such loss, claim, damage, liability or expense (or actions in
respect thereof as contemplated below) arises out of or is based upon any untrue or alleged
untrue statement of a material fact contained in the Registration Statement, the Disclosure
Package, any Issuer Free Writing Prospectus or the Prospectus (or any amendment or
supplement thereto) or arises out of or is based upon the omission or alleged omission to
state therein a material fact required to be stated therein or necessary to make the
statements therein not misleading, in each case to the extent, and only to the extent, that
such untrue statement or alleged untrue statement or omission or alleged omission was made
in the Registration Statement, the Disclosure Package, any Issuer Free Writing Prospectus or
the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity
with written information furnished to the Company by the Placement Agent expressly for use
therein; and to reimburse the Company, or any such director, officer, employee,
representative or controlling person for any and all expenses (including the fees and
disbursements of counsel chosen by such indemnitee) reasonably incurred by the Company or
any such director, officer, employee, representative, agent or controlling person in
connection with investigating, defending, settling, compromising, appearing as a third party
witness or

20

 

paying any such loss, claim, damage, liability, expense or action. The Company hereby
acknowledges that the only information that the Placement Agent has furnished to the Company
expressly for use in the Registration Statement, the Disclosure Package, any Issuer Free
Writing Prospectus or the Prospectus (or any amendment or supplement thereto) are the
statements set forth in the second sentence of the third paragraph of the Prospectus
Supplement under the caption “Plan of Distribution.” The indemnity agreement set forth in
this Section 8(b) shall be in addition to any liabilities that the Placement Agent might
otherwise have.

     (c) Promptly after receipt by an indemnified party under this Section 8 of notice of
the commencement of any action, such indemnified party will, if a claim in respect thereof
is to be made against an indemnifying party under this Section 8, notify the indemnifying
party in writing of the commencement thereof; but the failure to so notify the indemnifying
party (i) will not relieve it from liability under paragraph (a) or (b) above unless and to
the extent it did not otherwise learn of such action and such failure results in the
forfeiture by the indemnifying party of substantial rights and defenses and (ii) will not,
in any event, relieve the indemnifying party from any liability other than the
indemnification obligation provided in paragraph (a) or (b) above. In case any such action
is brought against any indemnified party and such indemnified party seeks or intends to seek
indemnity from an indemnifying party, the indemnifying party will be entitled to participate
in, and, to the extent that it shall elect, jointly with all other indemnifying parties
similarly notified, by written notice delivered to the indemnified party promptly after
receiving the aforesaid notice from such indemnified party, to assume the defense thereof
with counsel reasonably satisfactory to such indemnified party; provided, however, if the
defendants in any such action include both the indemnified party and the indemnifying party
and the indemnified party shall have reasonably concluded (based on the advice of counsel to
the indemnified party) that a conflict exists between the positions of the indemnifying
party and the indemnified party in conducting the defense of any such action or that there
may be legal defenses available to it and/or other indemnified parties that are different
from or additional to those available to the indemnifying party, the indemnified party or
parties shall have the right to select separate counsel to assume such legal defenses and to
otherwise participate in the defense of such action on behalf of such indemnified party or
parties. Upon receipt of notice from the indemnifying party to such indemnified party of
such indemnifying party’s election so to assume the defense of such action and approval by
the indemnified party of counsel, the indemnifying party will not be liable to such
indemnified party under this Section 8 for any legal or other expenses subsequently incurred
by such indemnified party in connection with the defense thereof unless (i) the indemnified
party shall have employed separate counsel in accordance with the proviso to the preceding
sentence (it being understood, however, that the indemnifying party shall not be liable for
the expenses of more than one separate counsel (other than local counsel), reasonably
approved by the indemnifying party, representing the indemnified parties who are parties to
such action) or (ii) the indemnifying party shall not have employed counsel reasonably
satisfactory to the indemnified party to represent the indemnified party within a reasonable
time after notice of commencement of the action, in each of which cases the fees and
expenses of counsel shall be at the expense of the indemnifying party.

21

 

     (d) The indemnifying party under this Section 8 shall not be liable for any settlement
of any proceeding effected without its written consent, but if settled with such consent or
if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify
the indemnified party against any loss, claim, damage, liability or expense by reason of
such settlement or judgment. No indemnifying party shall, without the prior written consent
of the indemnified party, effect any settlement, compromise or consent to the entry of
judgment in any pending or threatened action, suit or proceeding in respect of which any
indemnified party is or could have been a party and indemnity was or could have been sought
hereunder by such indemnified party, unless such settlement, compromise or consent (i)
includes an unconditional release of such indemnified party from all liability on claims
that are the subject matter of such action, suit or proceeding and (ii) does not include a
statement as to or an admission of fault, culpability or a failure to act, by or on behalf
of any indemnified party.

     (e) To the extent the indemnification provided for in Section 8(a) or 8(b) is
unavailable to an indemnified party or insufficient in respect of any loss, claim, damage,
liability, expense or action referred to therein, then each indemnifying party under such
paragraph, in lieu of indemnifying such indemnified party thereunder, shall contribute to
the amount paid or payable by such indemnified party as a result of such loss, claim,
damage, liability, expense or action (i) in such proportion as is appropriate to reflect the
relative benefits received by the Company on the one hand and the Placement Agent on the
other hand from the offering of the Shares or (ii) if the allocation provided by clause (i)
above is not permitted by applicable law, in such proportion as is appropriate to reflect
not only the relative benefits referred to in clause (i) above but also the relative fault
of the Company on the one hand and of the Placement Agent on the other hand in connection
with the statements or omissions that resulted in such loss, claim, damage, liability,
expense or action, as well as any other relevant equitable considerations. The relative
benefits received by the Company on the one hand and the Placement Agent on the other hand
in connection with the offering of the Shares shall be deemed to be in the same respective
proportions as the net proceeds from the offering of the Shares (before deducting expenses)
received by the Company and the total commissions received by the Placement Agent, in each
case as set forth in the table on the cover of the Prospectus, bear to the aggregate net
proceeds. The relative fault of the Company on the one hand and the Placement Agent on the
other hand shall be determined by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission or alleged omission to state a
material fact relates to information supplied by the Company or by the Placement Agent and
the parties’ relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission.

     (f) The Company and the Placement Agent agree that it would not be just or equitable if
contribution pursuant to this Section 8 were determined by pro rata allocation or by any
other method of allocation that does not take account of the equitable considerations
referred to in Section 8(e). The amount paid or payable by an indemnified party as a result
of the losses, claims, damages, liabilities, expenses and actions referred to in Section
8(e) shall be deemed to include, subject to the limitations set forth above,

22

 

any legal or other expenses reasonably incurred by such indemnified party in connection
with investigating or defending any such action or claim. Notwithstanding the provisions of
this Section 8, the Placement Agent shall not be required to contribute any amount in excess
of the amount by which the total price at which the Shares were sold and distributed to the
public exceeds the amount of any damages that the Placement Agent has otherwise been
required to pay by reason of such untrue or alleged untrue statement or omission or alleged
omission. No person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Act) shall be entitled to contribution from any person who was not guilty of
such fraudulent misrepresentation. The remedies provided for in this Section 8 are not
exclusive and shall not limit any rights or remedies which may otherwise be available to any
indemnified party at law or in equity.

     (g) The indemnity and contribution provisions contained in this Section 8 and the
representations, warranties and other statements of the Company contained in this Agreement
shall remain operative and in full force and effect regardless of (i) any termination of
this Agreement, (ii) any investigation made by or on behalf of the Placement Agent, any
person controlling the Placement Agent or any affiliate of the Placement Agent or by or on
behalf of the Company, its officers or directors or any person controlling the Company and
(iii) delivery of the Shares.

     9. Relationship of Parties.

     (a) The Company acknowledges and agrees that: (i) the placement of the Shares pursuant
to this Agreement, including the determination of commissions, is an arm’s-length commercial
transaction between the Company, on the one hand, and the Placement Agent, on the other
hand, and the Company is capable of evaluating and understanding, and understands and
accepts the terms, risks and conditions of, the transactions contemplated by the Agreement;
(ii) in connection with each transaction contemplated hereby and the process leading to such
transaction, the Placement Agent is and has been acting solely for its own account and is
not the financial advisor or fiduciary of the Company, its affiliates, stockholders,
creditors or employees, or any other party; (iii) the Placement Agent has not assumed nor
will it assume an advisory or fiduciary responsibility in favor of the Company with respect
to any of the transactions contemplated hereby or the process leading thereto (irrespective
of whether the Placement Agent has advised or is currently advising the Company on other
matters), and the Placement Agent has no obligation to the Company with respect to the
offering contemplated hereby except the obligations expressly set forth in this Agreement;
(iv) the Placement Agent and its affiliates may be engaged in a broad range of transactions
that involve interests that differ from those of the Company, and the Placement Agent has no
obligation to disclose any such interests by virtue of any advisory or fiduciary
relationship; and (v) the Placement Agent has not provided any legal, accounting, regulatory
or tax advice with respect to the offering contemplated hereby, and the Company has
consulted its own legal, accounting, regulatory and tax advisors to the extent it deemed
appropriate. The Company hereby waives and releases, to the fullest extent permitted by
law, any claims that the Company may have against the Placement Agent with respect to any
breach or alleged breach of fiduciary duty.

23

 

     (b) The Company will make available to the Placement Agent all information concerning
the business, assets, operations and financial condition of the Company which the Placement
Agent reasonably requests, and all such information shall be accurate and complete in all
material respects. Except as otherwise provided herein, the Company will be solely
responsible for the contents of the Disclosure Package.

     (c) This Agreement supersedes all prior agreements and understandings (whether written
or oral) between the Company, on the one hand, and the Placement Agent, on the other, with
respect to the subject matter hereof.

     10. Notices. Except as otherwise herein provided, all statements, requests, notices and
agreements shall be in writing and, if to the Placement Agent, shall be sufficient in all respects
if delivered or sent to (i) Stephens Inc., 111 Center Street, Little Rock, Arkansas 72201,
Attention: Joseph S. Mowery, with copies to Alston & Bird LLP, 1201 West Peachtree Street, Atlanta,
Georgia 30309, Attention: M. Hill Jeffries; if to the Company, shall be sufficient in all respects
if delivered or sent to the Company at the offices of the Company at 2000 Technology Parkway,
Newark, New York 14513, Attention: Peter F. Comerford, with copies to Harter Secrest & Emery LLP,
1600 Bausch & Lomb Place, Rochester, New York 14604, Attention: Jeffrey H. Bowen.

     11. Governing Law. This Agreement and any claim, counterclaim or dispute of any kind or nature
whatsoever arising out of or in any way relating to this Agreement (“Claim”), directly or
indirectly, shall be governed by, and construed in accordance with, the laws of the State of
Arkansas.

     12. Waiver of Jury Trial. Each of the Placement Agent and the Company (on its behalf and, to
the extent permitted by applicable law, on behalf of its stockholders and affiliates) waives all
right to trial by jury in any action, proceeding or counterclaim (whether based upon contract, tort
or otherwise) in any way arising out of or relating to this Agreement.

     13. Parties at Interest. The Agreement herein set forth has been and is made solely for the
benefit of the Placement Agent and the Company and to the extent provided in Section 8 hereof any
person or entity entitled to indemnification thereunder, and their respective successors, assigns,
heirs, personal representatives and executors and administrators. No other person, partnership,
association or corporation (including a purchaser, as such purchaser, from the Placement Agent)
shall acquire or have any right under or by virtue of this Agreement.

     14. Counterparts. This Agreement may be signed by the parties in one or more counterparts,
which together shall constitute one and the same agreement among the parties. In the event that any
signature is delivered by facsimile transmission, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is executed) with the same
force and effect as if such facsimile signature were the original thereof.

24

 

     15. Successors and Assigns. This Agreement shall be binding upon the Placement Agent and the
Company and their successors and assigns and any successor or assign of the Company’s and the
Placement Agent’s respective businesses and/or assets.

     16. Headings. The section headings in this Agreement have been inserted as a matter of
convenience of reference and are not a part of this Agreement.

     If the foregoing correctly sets forth the understanding between the Company and the Placement
Agent, please so indicate in the space provided below for that purpose, whereupon this Agreement
and your acceptance shall constitute a binding agreement between the Company and the Placement
Agent.

Very truly yours,

ULTRALIFE BATTERIES, INC.

	 	 	 	 	 
	By:	 	/s/ Robert W. Fishback
	 	 	 
	 

	 	Name:
	 	Robert W. Fishback
	 

	 	Title:
	 	Vice President-Finance and Chief Financial Officer

Accepted and agreed to as of the date first above written, on behalf of itself,

STEPHENS INC.

	 	 	 	 	 
	By:	 	/s/ Joseph S. Mowery
	 	 	 
	 

	 	Name:
	 	Joseph S. Mowery
	 

	 	Title:
	 	Managing Director

25

 

Exhibit A

ISSUER FREE WRITING PROSPECTUSES

Filed Pursuant to Rule 433

Issuer Free Writing Prospectus dated November 8, 2007

Relating to Prospectus Supplement dated November 8, 2007

to Prospectus dated September 22, 2006

Registration No. 333-136742

1,000,000 Shares

Ultralife Batteries, Inc.

Common Stock

TERM SHEET

	 	 	 
	 
	 	 
	Issuer

	 	Ultralife Batteries, Inc.
	 
	 	 
	Ticker/Exchange

	 	ULBI/NASDAQ Global Market
	 
	 	 
	Offering size

	 	1,000,000 shares by the issuer
	 
	 	 
	Over-allotment option

	 	None
	 
	 	 
	Public offering price

	 	$13.50 per share
	 
	 	 
	Sales commission

	 	$0.675 per share
	 
	 	 
	Net proceeds to issuer

	 	$12.575 million, of which approximately $6.0
million will be used to fund the acquisition of
Stationary Power Services, Inc., approximately $4.5
million will be used to repay borrowings related to
recent acquisitions and remaining amounts will be
used for general working capital purposes.
	 
	 	 
	Trade date

	 	November 9, 2007
	 
	 	 
	Settlement date:

	 	November 15, 2007
	 
	 	 
	Placement agent

	 	Stephens Inc.

The issuer has filed a registration statement (including a prospectus) with the SEC for the
offering to which this communication relates. Before you invest, you should read the prospectus in
that

A-1

 

registration statement and other documents the issuer has filed with the SEC for more complete
information about the issuer and this offering. You may get these documents for free by visiting
EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer or the placement agent will
arrange to send you the prospectus if you request it by calling Stephens Inc. toll-free at
1-800-643-9691.

Any disclaimer or other notice that may appear below is not applicable to this communication and
should be disregarded. Such disclaimer or notice was automatically generated as a result of this
communication being sent by Bloomberg or another email system.

2

 

Exhibit B

	 	 	 	 	 	 	 
	 	 	Name	 	Number of Shares:
	 
	1.

	 	Daniel W. Christman
	 	 	2,000	 
	2.

	 	Ranjit C. Singh
	 	 	12,000	 
	3.

	 	Paula H.J. Cholmondeley
	 	 	4,000	 

B-1

 

Exhibit C

FORM OF LOCK-UP AGREEMENT

November 8, 2007

Stephens Inc.

111 Center Street

Little Rock, Arkansas 72201

Re: Ultralife Batteries, Inc. (the “Company”)

Ladies and Gentlemen:

     The undersigned is an owner of record or beneficially of shares of Common Stock of the Company
(“Common Stock”) or securities convertible into or exchangeable or exercisable for Common Stock.
The Company proposes to issue and sell shares of its Common Stock (the “Offering”) for which you
will act as the placement agent. The undersigned acknowledges that you are relying on the
representations and agreements of the undersigned contained in this letter in carrying out the
Offering and in entering into placement arrangements with the Company with respect to the Offering.

     In consideration of the foregoing, the undersigned hereby agrees that the undersigned will not
(and will cause any spouse or immediate family member of the spouse or the undersigned living in
the undersigned’s household not to), without the prior written consent of Stephens Inc.
(“Stephens”) (which consent may be withheld in its sole discretion), directly or indirectly, sell,
offer, contract or grant any option to sell (including without limitation any short sale), pledge,
establish an open “put equivalent position” or liquidate or decrease a “call equivalent position”
within the meaning of Rule 16a-1(h) under the Securities Exchange Act of 1934, as amended, or
otherwise dispose of or transfer (or enter into any transaction which is designed to, or might
reasonably be expected to, result in the disposition or transfer of), including the filing (or
participation in the filing) of a registration statement (except for a registration statement on
Form S-8) with the Securities and Exchange Commission in respect of, any shares of Common Stock,
options to acquire shares of Common Stock, or securities exchangeable or exercisable for or
convertible into shares of Common Stock currently or hereafter owned either of record or
beneficially (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended) by
the undersigned (or such spouse or family member), or publicly announce an intention to do any of
the foregoing, for a period commencing on the date hereof and continuing through the close of
trading on the date 75 days after the date of the Prospectus Supplement relating to the Offering
(the “Lock-Up Period”). The foregoing sentence shall not apply to (i) a sale of any or all of the
shares of Common Stock owned by the undersigned pursuant to a “Rule 10b5-1 plan” of the
undersigned, (ii) a bona fide gift or gifts or (iii) the transfer of any or all of the shares of
Common Stock owned by the undersigned, either during his or her lifetime or on death, by gift, will
or intestate succession to the immediate family of the undersigned or to a trust the

B-2

 

beneficiaries of which are exclusively the undersigned and/or a member or members of his or
her immediate family; provided, however, that in each of (ii) and (iii) above, it shall be a
condition to such transfer that the transferee executes and delivers to Stephens an agreement
stating that the transferee is receiving and holding the Common Stock subject to the provisions of
this letter agreement, and there shall be no further transfer of such Common Stock except in
accordance with this letter. In addition, the undersigned agrees that, without the prior written
consent of Stephens, it will not, during the Lock-Up Period, make any demand for or exercise any
right with respect to, the registration of any shares of Common Stock or any security convertible
into or exercisable or exchangeable for Common Stock.

     If (i) the Company issues an earnings release or material news, or a material event relating
to the Company occurs, during the last 17 days of the Lock-Up Period, or (ii) prior to the
expiration of the Lock-Up Period, the Company announces that it will release earnings results
during the 16-day period beginning on the last day of the Lock-Up Period, the restrictions imposed
by this agreement shall continue to apply until the expiration of the 18-day period beginning on
the issuance of the earnings release or the occurrence of the material news or material event,
unless Stephens waives, in writing, such extension. The undersigned hereby acknowledges that the
Company has agreed in the Placement Agency Agreement to provide notice of any event that would
result in an extension of the Lock-Up Period pursuant to the previous paragraph to the undersigned
(in accordance with Section 5(j) of the Placement Agency Agreement) and agrees that any such notice
properly delivered will be deemed to have given to, and received by, the undersigned. The
undersigned hereby further agrees that, prior to engaging in any transaction or taking any other
action that is subject to the terms of this Lock-Up Agreement during the period from the date of
this Lock-Up Agreement to and including the 34th day following the expiration of the initial
Lock-Up Period, it will give notice thereof to the Company and will not consummate such transaction
or take any such action unless it has received written confirmation from the Company that the
Lock-Up Period (as such may have been extended pursuant to the previous paragraph) has expired.

     The undersigned also agrees and consents to the entry of stop transfer instructions with the
Company’s transfer agent and registrar against the transfer of shares of Common Stock or securities
convertible into or exchangeable or exercisable for Common Stock held by the undersigned except in
compliance with the foregoing restrictions.

     It is understood that if (a) the Company advises Stephens in writing that the parties do not
intend to proceed with the Offering, (b) either the Company or Stephens shall advise the other
party in writing that the Offering has been terminated, (c) the Placement Agency Agreement does not
become effective, or (d) the Placement Agency Agreement (other than the provisions thereof which
survive termination) shall terminate or be terminated prior to payment for and delivery of the
Common Stock to be sold thereunder, then the undersigned will be released from all obligations
under this letter.

     With respect to the Offering only, the undersigned waives any registration rights relating to
registration under the Securities Act of 1933, as amended, of any Common Stock owned either of
record or beneficially by the undersigned, including any rights to receive notice of the Offering.

B-3

 

     This agreement is irrevocable and will be binding on the undersigned and the respective
successors, heirs, personal representatives and assigns of the undersigned.

	 	 	 
	 
	 	 
	 
	Printed Name of Holder

	 
	 	 
	By:
	 	 
	 
	Signature

	 
	 	 
	 
	Printed Name of Person Signing

B-4

 

Exhibit D

OFFICERS’ CERTIFICATE

     1. We have reviewed the Placement Agency Agreement, the Registration Statement, the Disclosure
Package and the Prospectus, each as defined in the Placement Agency Agreement, and all of the
documents incorporated by reference in such documents.

     2. The representations and warranties of the Company as set forth in the Placement Agency
Agreement are true and correct in all material respects as of the time of purchase.

     3. The Company has performed in all material respects all of its obligations under the
Placement Agency Agreement that are to be performed at or before the time of purchase.

     4. The conditions set forth in Section 6(f) of the Placement Agency Agreement have been fully
satisfied.

     5. Subsequent to the respective dates as of which information is given in the Disclosure
Package and the Prospectus, there has not been (i) any event that has had, or that reasonably could
be expected to have, a Material Adverse Effect, (ii) any transaction which is material to the
Company or any Subsidiary and not disclosed in the Disclosure Package, except obligations and
liabilities incurred in the ordinary course of business consistent with past practice, (iii) any
obligation or liability, direct or contingent (including any off-balance sheet obligations),
incurred by the Company or any Subsidiary, which is material to the Company and its Subsidiaries
taken as a whole, except obligations and liabilities incurred in the ordinary course of business
consistent with past practice, (iv) any change in the capital stock of the Company or any
Subsidiary (except for the issuance of shares of Common Stock upon conversion of existing
convertible securities and exercise by employees of existing stock options disclosed as outstanding
in the Disclosure Package and the grant to employees, under the Company Stock Plans, of stock
options and shares of restricted stock that are not exercisable or vested, as the case may be,
during the Lock-up Period) or (v) any dividend or distribution of any kind declared, paid or made
on the capital stock of the Company.

     6. Subsequent to the execution of the Placement Agency Agreement, there has occurred no event
required to be set forth in an amendment or supplement to the Registration Statement, the
Disclosure Package or the Prospectus which has not been so set forth; there has been no Issuer Free
Writing Prospectus required to be filed under Rule 433(d) of the Commission that has not been so
filed; and there has been no document required to be filed under the Exchange Act and the rules and
regulations of the Commission thereunder that upon such filing would be deemed to be incorporated
by reference into the Disclosure Package or the Prospectus that has not been so filed.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}]]